Member Info for thetriplestar

If you are "holding until one day," the Farmout is that "one day." It is the transition from a 9.3 billion share anchor to a producing revenue stream. You don't need a buyout to get your money back; you need the Institutional Re-rating that happens when a giant puts their logo on the Rukwa project.

1. Raglan Acquisition = 7x Value Multiplier (FACT)

ECR bought the Raglan Project for A$1.01 million.

Today’s RNS confirms a Phase 1 gross gold value of A$7 million.

The Bottom Line: This isn't a "hope." The company has already identified 7x its purchase price in gold sitting in the top 1.5m of the riverbed.

2. The "Shield" of £39 Million (FACT)

ECR holds A$76 million (~£39 million) in unutilised tax losses in Australia.

The Bottom Line: While other miners lose 25% of their profit to the Australian government, ECR keeps almost 100% of its cash from Raglan and Blue Mountain until that £39m is exhausted. This is a massive "hidden" valuation booster.

3. Directors have "Skin in the Game" (FACT)

On January 8, 2026, the board took millions of shares in lieu of cash salary at a price of 0.2836p.

The Bottom Line: The directors aren't "draining the coffers." They are tied to the same share price you are. They only get paid "real money" if the stock price rises.

4. The Assets are Already Paid For (FACT)

The Raglan wash plant and equipment have an insurance replacement value of A$1.9 million.

The Bottom Line: ECR owns a turnkey mining operation that is worth nearly double what they paid for the entire project. This creates a "hard floor" for the company's valuation.

5. We have a "Blue Mountain" Giant in the Wings (FACT)

Raglan is just the "pilot." The company is currently advancing the Environmental Impact Assessment (EIA) for Blue Mountain.

The Bottom Line: Blue Mountain is expected to produce 500oz/year (nearly double Raglan). Raglan provides the cash flow to fund this expansion without further dilution.

6. Cash Position is Solid (FACT)

Following the January fundraising, ECR is sitting on approximately £1.5 million in cash.

The Bottom Line: The company is fully funded for its 2026 activities. They aren't "desperate" for a raise; they are "building for revenue."

The 4.6x volume spike suggests the market is shifting from speculative retail traders to institutional accumulation. The "Wave" is just beginning to form.

The market is completely ignoring the fact that Solvonis has a Phase 3 asset and is being run by a board that includes a former Executive VP from Gilead (Paul Carter), who knows exactly how to navigate a £1b+ exit

If SVNS re-rates to just 10% of its peer MindMed, the price would be roughly 1.80p

The latest presentation explicitly calls out a "Material valuation gap to peers". This is the "crazy" part you’re feeling—the company is being valued as a "penny stock" while its peers are multi-billion dollar entities:

Solvonis ($SVNS): Currently valued at £20–25m with a Phase 3 asset.

MindMed ($MNM): Valued at £1.25b with a Phase 3 asset.

Atai Life Sciences ($ATAI): Valued at £1b–£1.25b with a Phase 2 asset.

The AbbVie Benchmark: A private peer was recently bought by AbbVie for £1b.

While the share price is down 14% today, the gold hasn't moved.

ECR Market Cap at 0.29p: ~£9.5 million.

ECR Asset Value (Phase 1 Gold + Plant): ~£4.5 million.

ECR Tax Shield Value: ~£39 million.

When a company's "Tax Shield" alone is worth 4x its entire market value, and its "Phase 1" gold covers nearly 50% of the market cap, you are looking at an extreme Value Disconnect. This is exactly where professional "Value Investors" start stepping in.

I’m not 'getting burnt' by the helium; I’m calling out the people holding the fire extinguisher who seem more interested in guarding their seats than growing our value. If wanting a Board that respects capital and communicates transparently means I 'shouldn't be in AIM,' then perhaps AIM has forgotten what it was built for.

Every time the stock builds a 'fire' of momentum, the Board has historically doused it with a placing or a share issuance. With nearly 9.3 billion shares in issue, they have effectively capped the upside. A management team that understands 'Value' protects the capital structure; a 'Wet Blanket' board treats the share register like an ATM.

As of early 2026, the combined shareholding of the Board remains a fraction of the total register. While retail investors have funded every drill bit and every pump in the Rukwa since 2020, the Board continues to draw six-figure salaries. When management's primary income is their salary rather than the share price, they aren't incentivised effectively

The Board is currently "guarding the field," and their silence is a choice. They know exactly how much anxiety this causes retail investors, but as we discussed, their salaries are covered by the Colorado revenue, so they aren't feeling the "burn" that we are.

We have now hit 22 days since the pump was "running in hole." This officially pushes us past the "two to three weeks" timeline the Board gave on January 19th. The "wet blankets" are living up to their name, leaving shareholders in a complete information vacuum.

It has been exactly 21 days since the January 19th update. In that RNS, they stated the testing phase would take "two to three weeks." We are now at the upper limit of that window.......

As soon as the first "Quarterly Financials" RNS comes out showing "Profit: A500k/TaxPaid:A0," the market will suddenly "wake up" to the value of that A$76m shield....If ECR successfully "monetises" even 10% of that tax loss this year, the 0.58p target might actually be considered too low.

The Math: 25% of A76million=A19 million (~£10 million) - This is the actual amount of cash that ECR would have paid to the Australian government but will now keep in its own bank account as it becomes profitable. if a larger mining company (like Evolution Mining or Newmont) looks at ECR, they don't just see the gold. They see a "Tax Asset" they can buy.

If a major buys ECR for £20m, they effectively "inherit" the ability to shield £39m of their own Australian profits.

This makes ECR a cheaper acquisition for a big player than a similar company without the losses.

This creates a "Soft Floor" under the share price. It’s hard for the stock to stay at 0.35p when the tax asset alone is worth nearly half the company's value.

Brokers rarely give full value to a project that isn't pouring gold yet. As soon as the first gold bar is sold under that new offtake agreement, the "risk" in their model drops, which could lead them to raise the target.

Also, Lolworth is the "Bonus" - The 0.58p target mostly ignores the massive Lolworth Gold-Silver Project. Oak views Lolworth as "exploration upside." If ECR hits a major discovery there while Raglan is paying the bills, the 0.58p target would likely be considered conservative.

Don't let the lack of immediate price action today fool you; the fundamentals are moving 10x faster than the ticker. We are watching the rare transition of a junior explorer into a self-funded producer.

The "Asset Floor": The board just confirmed the insurance replacement value for the Raglan gear is A$1.9m (£1m). Think about that—the wash plant, gold room, and fleet alone cover nearly 10% of the current market cap. This doesn't even account for the gold in the ground or the A$76m tax shield!

The Offtake De-Risking: The "Proposed Offtake Partner" news is the final piece of the puzzle. We aren't just "finding" gold; we’ve already visited the refinery and are finalizing the contract this month. No more dilutive raises to keep the lights on—we are moving to actual cash flow.

The Math at $5,000 Gold: With gold at these levels, Raglan and Blue Mountain aren’t just "projects"—they are cash machines. Oak Securities isn't picking a 0.58p price target out of thin air. We are currently sitting ~40% below that target while the board is literally on the ground in Queensland pouring the foundation for the first gold bar.

Bottom Line: Volume is high, "Sells" are being absorbed, and the 52-week high (0.43p) is the only thing standing between us and 0.50p+. I’m holding for the "First Gold" RNS. The "Show Me" phase is almost over, and the "Pay Me" phase is about to begin....

The recent drift to 0.25p is a gift. We are seeing a classic "forced washout" (likely silver-crash margin calls) meeting a rock-solid floor.

Why I’m holding for the re-rate:

Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%—they are CNS pros building for a major exit.

The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from "AI discovery" to "clinical reality."

Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the "Prozac-sized" depression market have fundamentally changed the valuation floor.

Buyout Potential: At an £18m market cap, we are a "snack" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels.

The seller is running dry and the news is incoming. For those with averages in the 30s—patience pays here. The science is better than it’s ever been.

It will be fascinating to see what happens

DGR have not produced a rival bidder. Without a "White Knight" actually putting cash on the table, DGR Global’s protest is unlikely to stop the deal, especially since BHP and Newmont have already signed legal pledges (irrevocable undertakings) to vote "Yes."

The Scheme Document was published on January 21, 2026. Here are the hard dates:

The Vote: The Court Meeting and General Meeting will happen on February 23, 2026.

The Last Day of Trading: March 3, 2026. After this, the stock will be suspended.

Money in Your Account: Cheques and electronic transfers are expected to be processed by March 18, 2026.